1-12 of 12
Emily Curran
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updates of R/R CLL with prior exposure to Bruton's tyrosine kinase (BTK) inhibitor and/or bcl-2 inhibitor in the Phase 1 trial of LP-168 (Rocbrutinib), a novel COVALENT and non-COVALENT BTK inhibitor

Free
Jennifer Woyach, Danielle Brander, Boyu Hu, Kerry Rogers, Zulfa Omer, Emily Curran, Deborah Stephens, Andrea Sitlinger, Yi Chen, Stephen Anthony, Yu Chen, Kewei Shang, John Byrd
Journal: Blood
Blood (2025) 146 (Supplement 1): 87.
https://doi.org/10.1182/blood-2025-87
Published: 2025
Journal Articles

Phase 1b safety run-in study followed by Phase 2 study of ficlatuzumab, azacitidine and venetoclax in untreated Acute Myeloid Leukemia patients aged ≥ 60 years old

Free
Emily Curran, Ying Huang, Shivani Handa, Ronan Swords, Eytan Stein, Maria Baer, Wendy Stock, Yazan Madanat, Rebecca Olin, William Blum, Gary Schiller, Tara Lin, Joshua Zeidner, Bradley Blaser, Molly Martycz, Leonard Rosenberg, Sonja Marcus, Timothy Chen, Mona Stefanos, Ashley Yocum, Ross Levine, Brian Druker, Uma Borate, Alice Mims, John Byrd
Journal: Blood
Blood (2025) 146 (Supplement 1): 3432.
https://doi.org/10.1182/blood-2025-3432
Published: 2025
Journal Articles

ZE74-0282 is a novel JH2 domain JAK2 inhibitor with promising pre-clinical activity in JAK2 V617F mutant diseases

Free
Shailaja Hegde, Alexander Khvat, Ruben Karapetian, Brian Ledwith, Fraser Pickersgill, Megan Johnstone, Eric Vick, Emily Curran, Iain Dukes, Amy Burd, Nikolay Savchuk, Vladislav Parchincky, Igor Rezekin, Erin Hertlein, John Byrd
Journal: Blood
Blood (2025) 146 (Supplement 1): 1988.
https://doi.org/10.1182/blood-2025-1988
Published: 2025
Journal Articles

A phase 2 study evaluating the safety and efficacy of first line asparaginase recombinant erwinia asparaginase (Rylaze) during pediatric-inspired regimen in high-risk adults with newly diagnosed ALL or lbl

Free
Hoda Pourhassan, Jianying Zhang, Wendy Stock, Mark Geyer, Anjali Advani, Jae Park, Emily Curran, Katrin Tiemann, Vaibhav Agrawal, Paul Koller, Jose Tinajero, Tibor Kovacsovics, Anthony Selwyn Stein, Guido Marcucci, Melisa Stricherz, Stefan Faderl, Vinod Pullarkat, Ibrahim Aldoss
Journal: Blood
Blood (2025) 146 (Supplement 1): 8233.
https://doi.org/10.1182/blood-2025-8233
Published: 2025
Journal Articles

RAS mutations negate the favorable impact of NPM1 in older patients with newly diagnosed Acute Myeloid Leukemia treated with ven/HMA

Free
Fieke Hoff, Alexander Li, Ying Huang, Rina Welkie, Ronan Swords, Elie Traer, Eytan Stein, Tara Lin, Maria Baer, Vu Duong, William Blum, Martha Arellano, Wendy Stock, Olatoyosi Odenike, Joshua Zeidner, Rebecca Olin, Catherine Smith, Gary Schiller, Emily Curran, Shivani Handa, Nyla Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Marcus, Leonard Rosenberg, Brian Druker, Ross Levine, Ashley Yocum, Uma Borate, Alice Mims, John Byrd, Yazan Madanat
Journal: Blood
Blood (2025) 146 (Supplement 1): 995.
https://doi.org/10.1182/blood-2025-995
Published: 2025
Journal Articles

Clinical and molecular characteristics of Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia with central nervous system relapse versus systemic relapse: Results from consortium on myeloid malignancies and neoplastic diseases (COMMAND)

Free
Rafael Madero-Marroquin, Ravi Kishore Narra, Alice Mims, Alexander Coltoff, Georgio Medawar, Brooke Hisrich, Rory Shallis, Cameron Hunter, Vamsi Kota, Tamer Othman, Brian Jonas, Shreya Desai, Guilherme Sacchi De Camargo Correia, Adam Duvall, Neil Palmisiano, Emily Curran, Zulfa Omer, Anjali Advani, Ehab Atallah, Mark Litzow, Anand Patel, Talha Badar
Journal: Blood
Blood (2025) 146 (Supplement 1): 3320.
https://doi.org/10.1182/blood-2025-3320
Published: 2025
Journal Articles

Prognostic risk integration for survival modeling (PRISM) in newly diagnosed acute myeloid leukemia treated with venetoclax:  a multinational retrospective cohort study

Free
Curtis Lachowiez, Andy Kaempf, Jad Othman, Seongseok Yun, Mael Heiblig, Michael Heuser, Rabia Shahswar, Anand Patel, Rafael Madero-Marroquin, Joseph Cannova, Irene Zacheo, Federica Monaco, Dimitrios Drekolias, Fatima Tuz Zahra, Amine Belhabri, Urbain Tauveron-Jalenques, Emmanuelle Tavernier, Martin Carre, Gaspar Aspas Requena, Nicola Long, Rachel Cook, Elie Traer, Ronan Swords, Jennifer Saultz, Jenny O'Nions, Faisal Basheer, John Laurie, Shivani Handa, Eytan Stein, Maria Baer, Wendy Stock, Rebecca Olin, William Blum, Gary Schiller, Tara Lin, Emily Curran, Ying Huang, Rina Welkie, Ashley Yocum, Giovanni Marconi, Ellen Madarang, Justin Watts, Yazan Madanat, Richard Dillon, Sanam Loghavi, Joshua Zeidner, Daniel Pollyea, Elsa Bernard
Journal: Blood
Blood (2025) 146 (Supplement 1): 453.
https://doi.org/10.1182/blood-2025-453
Published: 2025
Journal Articles

Title: Clinical trial availability and receipt of guideline concordant care among adolescents and young adults (AYAs) with acute lymphoblastic leukemia

Free
Julie Wolfson, Michelle Nuno, Abbie Kleckley, Allison Grimes, Michael Roth, Melissa Beauchemin, Subhash Ramakrishnan, David Dickens, Wendy Woods, Kandice Adams, Tawa Alabi, Jennifer Levine, Michele Scialla, Koh Boyaue, Olivia Ponce, Sarah Vargas, George Chang, Wendy Stock, Dawn Hershman, Emily Curran, Anjali Advani, Kristen O'Dwyer, Selina Luger, Jijun Liu, David Robert Freyer, Lillian Sung, Susan Parsons
Journal: Blood
Blood (2025) 146 (Supplement 1): 6190.
https://doi.org/10.1182/blood-2025-6190
Published: 2025
Journal Articles

A Phase 1 Dose Escalation Study of Dual PI3K and DNA PK Inhibitor, BR101801 in Adult Patients with Advanced Hematologic Malignancies

Free
Tae Min Kim, Dok Hyun Yoon, Ahmad H. Mattour, Jorge M. Chaves, Emily Curran, Yoon Kyung Jeon, Bong-Seog Kim, Seok Jin Kim
Journal: Blood
Blood (2021) 138 (Supplement 1): 3562.
https://doi.org/10.1182/blood-2021-149927
Published: 2021
Journal Articles

Taking a “BiTE out of ALL”: blinatumomab approval for MRD-positive ALL

Free
Clinical Trials & Observations
Emily Curran, Wendy Stock
Journal: Blood
Blood (2019) 133 (16): 1715–1719.
https://doi.org/10.1182/blood-2018-12-852376
Published: 2019
Journal Articles

How I treat acute lymphoblastic leukemia in older adolescents and young adults

Free
Clinical Trials & Observations
Emily Curran, Wendy Stock
Journal: Blood
Blood (2015) 125 (24): 3702–3710.
https://doi.org/10.1182/blood-2014-11-551481
Published: 2015
Journal Articles

Phase II Study of the Oral MEK Inhibitor AZD6244 in Advanced Acute Myeloid Leukemia (AML).

Free
Olatoyosi Odenike, Emily Curran, Neil Iyengar, Leslie Popplewell, Mark Kirschbaum, Harry P Erba, Margaret Green, Xavier Poiré, Pamela Ihonor, Ernesto Diaz-Flores, Kevin Shannon, Ehab Atallah, James L Wade, III, Maria Perdekamp, Sreenivasa Nattam, Sachdev P. Thomas, Scott E. Smith, L. Austin Doyle, Elizabeth Shima Rich, Richard A. Larson, Wendy Stock
Journal: Blood
Blood (2009) 114 (22): 2081.
https://doi.org/10.1182/blood.V114.22.2081.2081
Published: 2009